Meet Firm Perfection (Hibiscus)², a biotech active targeting inflammaging-related skin structural decline

Published: 10-May-2026

As inflammaging gains recognition as a key contributor to skin ageing, Naolys unveils a new biotech approach designed to support skin firmness, resilience and dermal architecture over time

Developed with Naolys’ proprietary Sister Cells™ technology, Firm Perfection (Hibiscus)² combines two complementary hibiscus cell strains to create a synergistic botanical approach inspired by the plant’s resilience and phytochemical richness.

The active is designed to support the biological coordination involved in maintaining skin structure and visible firmness.

Firm Perfection (Hibiscus)² reflects the growing industry focus on biomimetic and cell-based strategies that help preserve long-term skin functionality and structural performance.

Naolys will present Firm Perfection (Hibiscus)² at the NYSCC Suppliers’ Day 2026, alongside Aethelis Granata, its award-winning plant exosome active dedicated to skin longevity.

Meet the team at booth 2207.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
  2. You need to be a subscriber to read this article.
    Click here to find out more.
  3. You need to be a subscriber to read this article.
    Click here to find out more.

Relevant companies

You may also like